Form 4 for TRDA Entrada Therapeutics, Inc.
Accepted 2024-10-18 00:00:00 ET · period of report 2024-10-16 · accession 0001689375-24-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-18 | 2024-10-16 | TRDA | Sethuraman Natarajan | Pres, Research, Develop | S - Sale | $18.00 | -600 | 183.2K | -0.3% | -$10.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-16 | S | D | 600 | $18.00 | 183,216 | D | — | — |